計算
負債資本比率 | = | 負債1 | ÷ | 自己資本(赤字)1 | |
---|---|---|---|---|---|
2022/12/31 | — | = | 609,618) | ÷ | (107,900) |
2021/12/31 | 0.59 | = | 142,838) | ÷ | 243,863) |
2020/12/31 | 1.20 | = | 135,713) | ÷ | 113,383) |
2019/12/31 | — | = | 129,257) | ÷ | (10,937) |
2018/12/31 | 1.64 | = | 42,413) | ÷ | 25,934) |
2017/12/31 | 0.29 | = | 31,777) | ÷ | 109,842) |
2016/12/31 | 0.32 | = | 29,881) | ÷ | 94,361) |
2015/12/31 | 0.21 | = | 14,639) | ÷ | 68,590) |
2014/12/31 | 0.00 | = | —) | ÷ | 92,064) |
2013/12/31 | 0.00 | = | —) | ÷ | 54,442) |
2012/12/31 | 0.00 | = | —) | ÷ | 70,085) |
2011/12/31 | 0.00 | = | 152) | ÷ | 48,178) |
2010/12/31 | 0.01 | = | 985) | ÷ | 70,516) |
2009/12/31 | 0.03 | = | 2,601) | ÷ | 101,428) |
2008/12/31 | 0.09 | = | 4,640) | ÷ | 49,766) |
2007/12/31 | 0.09 | = | 8,689) | ÷ | 99,916) |
2006/12/31 | 0.10 | = | 10,835) | ÷ | 106,313) |
2005/12/31 | 0.13 | = | 9,362) | ÷ | 73,561) |
レポートに基づく: 10-K (報告日: 2022-12-31), 10-K (報告日: 2021-12-31), 10-K (報告日: 2020-12-31), 10-K (報告日: 2019-12-31), 10-K (報告日: 2018-12-31), 10-K (報告日: 2017-12-31), 10-K (報告日: 2016-12-31), 10-K (報告日: 2015-12-31), 10-K (報告日: 2014-12-31), 10-K (報告日: 2013-12-31), 10-K (報告日: 2012-12-31), 10-K (報告日: 2011-12-31), 10-K (報告日: 2010-12-31), 10-K (報告日: 2009-12-31), 10-K (報告日: 2008-12-31), 10-K (報告日: 2007-12-31), 10-K (報告日: 2006-12-31), 10-K (報告日: 2005-12-31).
1 千米ドル
競合他社との比較
Cytokinetics Inc. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | Vertex Pharmaceuticals Inc. | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2022/12/31 | — | 3.67 | 10.64 | 1.27 | 0.39 | 1.52 | 1.19 | 0.52 | 0.67 | 0.37 | 0.12 | 0.78 | 0.03 |
2021/12/31 | 0.59 | 4.98 | 4.97 | 1.24 | 0.49 | 1.88 | 1.27 | 0.46 | 0.87 | 0.50 | 0.14 | 0.85 | 0.06 |
2020/12/31 | 1.20 | 6.58 | 3.51 | 1.34 | 0.53 | 2.94 | 1.73 | 0.56 | 1.26 | 0.63 | 0.24 | 0.63 | 0.07 |
2019/12/31 | — | — | 3.09 | 0.91 | 0.72 | 5.88 | 1.09 | 0.47 | 1.02 | 0.83 | 0.06 | 0.60 | 0.09 |
2018/12/31 | 1.64 | — | 2.71 | 0.52 | 0.35 | 1.30 | 1.28 | 0.51 | 0.94 | 0.66 | 0.08 | 0.69 | 0.13 |
2017/12/31 | 0.29 | 7.33 | 1.40 | 0.68 | 0.40 | 1.18 | 1.64 | 0.57 | 0.71 | 0.60 | 0.11 | 0.83 | 0.29 |
2016/12/31 | 0.32 | 7.95 | 1.16 | 0.41 | 0.53 | 0.74 | 1.39 | 0.39 | 0.62 | 0.71 | 0.11 | 0.77 | 0.71 |
2015/12/31 | 0.21 | 8.03 | 1.12 | 0.47 | 0.54 | 0.55 | 1.20 | 0.28 | 0.59 | 0.60 | 0.10 | 0.59 | 0.86 |
2014/12/31 | 0.00 | 8.62 | 1.19 | 0.53 | 0.15 | 0.52 | 0.80 | 0.27 | 0.44 | 0.51 | 0.18 | 0.71 | 0.75 |
2013/12/31 | 0.00 | 3.28 | 1.45 | 0.55 | 0.16 | 0.30 | 0.58 | 0.25 | 0.50 | 0.48 | 0.26 | 0.62 | 0.36 |
2012/12/31 | 0.00 | 4.66 | 1.39 | 0.54 | 0.28 | 0.37 | 0.88 | 0.25 | 0.39 | 0.46 | 0.37 | 0.46 | 0.68 |
2011/12/31 | 0.00 | — | 1.13 | 0.34 | 0.31 | 0.52 | 1.13 | 0.34 | 0.32 | 0.47 | 0.90 | 0.47 | 0.58 |
2010/12/31 | 0.01 | — | 0.56 | 0.35 | 0.21 | 0.56 | 0.59 | 0.30 | 0.33 | 0.50 | 0.31 | 0.14 | 1.07 |
2009/12/31 | 0.03 | — | 0.47 | 0.43 | 0.25 | 0.70 | 0.18 | 0.29 | 0.30 | 0.54 | 0.27 | 0.14 | 0.14 |
2008/12/31 | 0.09 | — | 0.50 | 0.55 | 0.27 | 1.55 | 0.31 | 0.28 | 0.33 | 0.30 | 0.00 | 0.14 | 1.20 |
2007/12/31 | 0.09 | — | 0.63 | 0.59 | 0.41 | 0.37 | 0.38 | 0.22 | 0.32 | 0.20 | 0.43 | 0.15 | 0.07 |
2006/12/31 | 0.10 | — | 0.48 | 0.74 | 0.37 | 0.34 | 0.77 | 0.17 | 0.39 | 0.11 | 0.92 | 0.19 | 0.24 |
2005/12/31 | 0.13 | — | 0.19 | 0.77 | 0.21 | 0.60 | 0.10 | 0.07 | 0.45 | 0.27 | 1.75 | 0.21 | 0.75 |
レポートに基づく: 10-K (報告日: 2022-12-31), 10-K (報告日: 2021-12-31), 10-K (報告日: 2020-12-31), 10-K (報告日: 2019-12-31), 10-K (報告日: 2018-12-31), 10-K (報告日: 2017-12-31), 10-K (報告日: 2016-12-31), 10-K (報告日: 2015-12-31), 10-K (報告日: 2014-12-31), 10-K (報告日: 2013-12-31), 10-K (報告日: 2012-12-31), 10-K (報告日: 2011-12-31), 10-K (報告日: 2010-12-31), 10-K (報告日: 2009-12-31), 10-K (報告日: 2008-12-31), 10-K (報告日: 2007-12-31), 10-K (報告日: 2006-12-31), 10-K (報告日: 2005-12-31).
産業部門との比較: Pharmaceuticals, Biotechnology & Life Sciences
Cytokinetics Inc. | Pharmaceuticals, Biotechnology & Life Sciences | |
---|---|---|
2022/12/31 | — | 0.80 |
2021/12/31 | 0.59 | 0.93 |
2020/12/31 | 1.20 | 1.12 |
2019/12/31 | — | 1.09 |
2018/12/31 | 1.64 | 0.93 |
2017/12/31 | 0.29 | 0.87 |
2016/12/31 | 0.32 | 0.79 |
2015/12/31 | 0.21 | 0.68 |
2014/12/31 | 0.00 | 0.55 |
2013/12/31 | 0.00 | 0.52 |
2012/12/31 | 0.00 | 0.51 |
2011/12/31 | 0.00 | 0.46 |
2010/12/31 | 0.01 | 0.40 |
2009/12/31 | 0.03 | 0.39 |
2008/12/31 | 0.09 | 0.37 |
2007/12/31 | 0.09 | 0.30 |
2006/12/31 | 0.10 | 0.25 |
2005/12/31 | 0.13 | 0.29 |
レポートに基づく: 10-K (報告日: 2022-12-31), 10-K (報告日: 2021-12-31), 10-K (報告日: 2020-12-31), 10-K (報告日: 2019-12-31), 10-K (報告日: 2018-12-31), 10-K (報告日: 2017-12-31), 10-K (報告日: 2016-12-31), 10-K (報告日: 2015-12-31), 10-K (報告日: 2014-12-31), 10-K (報告日: 2013-12-31), 10-K (報告日: 2012-12-31), 10-K (報告日: 2011-12-31), 10-K (報告日: 2010-12-31), 10-K (報告日: 2009-12-31), 10-K (報告日: 2008-12-31), 10-K (報告日: 2007-12-31), 10-K (報告日: 2006-12-31), 10-K (報告日: 2005-12-31).
業界との比較: Health Care
Cytokinetics Inc. | Health Care | |
---|---|---|
2022/12/31 | — | 0.72 |
2021/12/31 | 0.59 | 0.80 |
2020/12/31 | 1.20 | 0.92 |
2019/12/31 | — | 0.90 |
2018/12/31 | 1.64 | 0.80 |
2017/12/31 | 0.29 | 0.82 |
2016/12/31 | 0.32 | 0.77 |
2015/12/31 | 0.21 | 0.69 |
2014/12/31 | 0.00 | 0.54 |
2013/12/31 | 0.00 | 0.50 |
2012/12/31 | 0.00 | 0.54 |
2011/12/31 | 0.00 | 0.47 |
2010/12/31 | 0.01 | 0.43 |
2009/12/31 | 0.03 | 0.42 |
2008/12/31 | 0.09 | 0.42 |
2007/12/31 | 0.09 | 0.36 |
2006/12/31 | 0.10 | 0.32 |
2005/12/31 | 0.13 | 0.30 |
レポートに基づく: 10-K (報告日: 2022-12-31), 10-K (報告日: 2021-12-31), 10-K (報告日: 2020-12-31), 10-K (報告日: 2019-12-31), 10-K (報告日: 2018-12-31), 10-K (報告日: 2017-12-31), 10-K (報告日: 2016-12-31), 10-K (報告日: 2015-12-31), 10-K (報告日: 2014-12-31), 10-K (報告日: 2013-12-31), 10-K (報告日: 2012-12-31), 10-K (報告日: 2011-12-31), 10-K (報告日: 2010-12-31), 10-K (報告日: 2009-12-31), 10-K (報告日: 2008-12-31), 10-K (報告日: 2007-12-31), 10-K (報告日: 2006-12-31), 10-K (報告日: 2005-12-31).